Biotech · Private company
iRenix Medical, Inc.
Track this companyFree. Adds iRenix Medical, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials31 recruiting or active
Pipeline programs4From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline4
- ControlPhase 3 · Diabetic Macular EdemaClinicalTrials.gov · fetched Nov 12, 2026
- IRX-101Phase 3 · Diabetic Macular EdemaClinicalTrials.gov · fetched Nov 12, 2026
- IRX-101Phase 3 · Retinal DiseaseClinicalTrials.gov · fetched Nov 12, 2026
- Providone-IodinePhase 3 · Retinal DiseaseClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials3
- Safety and Tolerability of IRX-101 in Patients Receiving Intravitreal InjectionsPHASE3 · NOT_YET_RECRUITING · started Sep 1, 2026ClinicalTrials.gov NCT05750589 · fetched Nov 12, 2026
- SteRilizing Eye SoLution to ImprovE Patient ComFort (RELIEF)PHASE2 · COMPLETED · started Feb 22, 2023ClinicalTrials.gov NCT05747430 · fetched Nov 12, 2026
- EffiCacy, Safety and ToLErability of a Novel Ocular ANtiseptic for Ocular Use (CLEAN)PHASE3 · TERMINATED · started Nov 15, 2021ClinicalTrials.gov NCT05127525 · fetched Nov 12, 2026